Co-Authors
This is a "connection" page, showing publications co-authored by RICHARD HURWITZ and MURALI CHINTAGUMPALA.
Connection Strength
0.567
-
Retinoblastoma: review of current management. Oncologist. 2007 Oct; 12(10):1237-46.
Score: 0.318
-
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol. 2005 Nov 01; 23(31):7927-35.
Score: 0.070
-
Retinoblastoma: from bench to bedside. Expert Rev Mol Med. 2003 Jan 07; 5(1):1-14.
Score: 0.057
-
Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma. Neuro Oncol. 2013 Sep; 15(9):1173-85.
Score: 0.029
-
Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr. 1992 Jan; 120(1):49-53.
Score: 0.027
-
A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models. Neuro Oncol. 2011 Jan; 13(1):14-27.
Score: 0.025
-
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther. 2010 Oct; 18(10):1885-90.
Score: 0.024
-
Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006 Nov; 130(11):1669-72.
Score: 0.019